METHYL 2-(CHLOROSULFONYL)-4-NITROBENZOATE, 90.0%, 250mg

N-(4-Methoxybenzyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine, 95.0%, 5g

5-(2-Chloroacetyl)-4-(trifluoromethyl)-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-2-one, 95%, 100mg

2-Aminohex-5-ynoic acid, 95%, 50mg

4'-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-4-fluorobenzophenone, 97.0%, 1g

(3aR,6R,6aR)-2,2,6-Trimethyl-6-vinyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-one, 98%, 1g

4-Phenylpiperidine, 97.0%, 1g

Tridecane-1,13-diol, 95.0%, 25g

Zinc chloride, min. 97%, pa, 500 g, plastic packaging.

4-Fluoro-2-methyl-1H-indole, 95.0%, 250mg

ETHYL 5-(DIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBOXYLATE, 95%, 5g

(4-Nitro-phenoxy)-acetic acid, 95.0%, 100g

3-Hydroxypiperidine hydrochloride, 98.0%, 10g